| Ten years with New Delhi metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design P Linciano, L Cendron, E Gianquinto, F Spyrakis, D Tondi ACS infectious diseases 5 (1), 9-34, 2018 | 144 | 2018 |
| Iron metabolism at the interface between host and pathogen: from nutritional immunity to antibacterial development M Marchetti, O De Bei, S Bettati, B Campanini, S Kovachka, E Gianquinto, ... International journal of molecular sciences 21 (6), 2145, 2020 | 61 | 2020 |
| Fluorescent nitric oxide photodonors based on BODIPY and rhodamine antennae C Parisi, M Failla, A Fraix, B Rolando, E Gianquinto, F Spyrakis, ... Chemistry–A European Journal 25 (47), 11080-11084, 2019 | 33 | 2019 |
| Binding of androgen-and estrogen-like flavonoids to their cognate (non) nuclear receptors: a comparison by computational prediction G D’Arrigo, E Gianquinto, G Rossetti, G Cruciani, S Lorenzetti, F Spyrakis Molecules 26 (6), 1613, 2021 | 30 | 2021 |
| Interaction of human hemoglobin and semi-hemoglobins with the Staphylococcus aureus hemophore IsdB: a kinetic and mechanistic insight E Gianquinto, I Moscetti, O De Bei, B Campanini, M Marchetti, FJ Luque, ... Scientific reports 9 (1), 18629, 2019 | 28 | 2019 |
| Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases F Spyrakis, M Santucci, L Maso, S Cross, E Gianquinto, F Sannio, ... Scientific Reports 10 (1), 12763, 2020 | 26 | 2020 |
| 4-Amino-1,2,4-triazole-3-thione as a Promising Scaffold for the Inhibition of Serine and Metallo-β-Lactamases P Linciano, E Gianquinto, M Montanari, L Maso, P Bellio, ... Pharmaceuticals 13 (3), 52, 2020 | 14 | 2020 |
| Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor S Gastaldi, V Boscaro, E Gianquinto, CF Sandall, M Giorgis, E Marini, ... Molecules 26 (13), 3975, 2021 | 12 | 2021 |
| The allosteric interplay between S‐nitrosylation and glycine binding controls the activity of human serine racemase F Marchesani, E Gianquinto, I Autiero, A Michielon, B Campanini, ... The FEBS Journal 288 (9), 3034-3054, 2021 | 11 | 2021 |
| Discovery of a novel 1, 3, 4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet … S Gastaldi, C Rocca, E Gianquinto, MC Granieri, V Boscaro, F Blua, ... European Journal of Medicinal Chemistry 257, 115542, 2023 | 9 | 2023 |
| Evaluation of Porcine and Aspergillus oryzae α-Amylases as Possible Model for the Human Enzyme M Marengo, D Pezzilli, E Gianquinto, A Fissore, S Oliaro-Bosso, ... Processes 10 (4), 780, 2022 | 9 | 2022 |
| Can we exploit β-lactamases intrinsic dynamics for designing more effective inhibitors? E Gianquinto, D Tondi, G D’Arrigo, L Lazzarato, F Spyrakis Antibiotics 9 (11), 833, 2020 | 9 | 2020 |
| Cryo-EM structures of staphylococcal IsdB bound to human hemoglobin reveal the process of heme extraction O De Bei, M Marchetti, L Ronda, E Gianquinto, L Lazzarato, ... Proceedings of the National Academy of Sciences 119 (14), e2116708119, 2022 | 8 | 2022 |
| Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein E Marini, M Marino, G Gionfriddo, F Maione, M Pandini, D Oddo, ... Molecules 27 (23), 8513, 2022 | 6 | 2022 |
| A community effort in SARS‐CoV‐2 drug discovery J Schimunek, P Seidl, K Elez, T Hempel, T Le, F Noé, S Olsson, L Raich, ... Molecular Informatics 43 (1), e202300262, 2024 | 4 | 2024 |
| Exploring ligand binding domain dynamics in the NRs superfamily G D’Arrigo, I Autiero, E Gianquinto, L Siragusa, M Baroni, G Cruciani, ... International Journal of Molecular Sciences 23 (15), 8732, 2022 | 3 | 2022 |
| Repurposing the trypanosomatidic GSK kinetobox for the inhibition of parasitic pteridine and dihydrofolate reductases M Santucci, R Luciani, E Gianquinto, C Pozzi, F Pisa, L Dello Iacono, ... Pharmaceuticals 14 (12), 1246, 2021 | 3 | 2021 |
| N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights … E Gianquinto, F Sodano, B Rolando, M Kostrzewa, M Allarà, ... Molecules 27 (23), 8152, 2022 | 2 | 2022 |
| Selective delivery of pentamidine toward cancer cells by self-assembled nanoparticles I Andreana, E Gazzano, E Gianquinto, G Piatti, V Bincoletto, D Kryza, ... International Journal of Pharmaceutics 625, 122102, 2022 | 2 | 2022 |
| Natural products as novel scaffolds for the design of glycogen synthase kinase 3β inhibitors S Montanari, C Seidl, L Davani, E Gianquinto, E Emrichova, C Terenzi, ... Expert Opinion on Drug Discovery 17 (4), 377-396, 2022 | 2 | 2022 |
